# Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck

> **NCT01427478** · PHASE3 · COMPLETED · sponsor: **Centre Leon Berard** · enrollment: 134 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** AFATINIB
- **DRUG:** Placebo of AFATINIB

## Key facts

- **NCT ID:** NCT01427478
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2020-11
- **Final completion:** 2021-05
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2021-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01427478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01427478, "Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01427478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*